Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Lunai Bioworks Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +4 vs. Q3 2025
- Shares held
- 1.11M
- −47.3K (−4.1%) vs. Q3 2025
- Total value
- $981.7K
- −$398.7K (−28.9%) vs. Q3 2025
- New holders
- 9
- 5 more added
- Sold out
- 5
- 7 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LNAI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $641.0K |
| Q1 2026 | 29 | $403.3K |
| Q4 2025 | 24 | $981.7K |
| Q3 2025 | 20 | $1.38M |
| Q2 2025 | 45 | $4.17M |
| Q1 2025 | 63 | $12.0M |
| Q4 2024 | 58 | $18.5M |
| Q3 2024 | 50 | $7.13M |
| Q2 2024 | 39 | $24.8M |
| Q1 2024 | 41 | $19.2M |
| Q4 2023 | 36 | $8.16M |
| Q3 2023 | 21 | $6.65M |
| Q2 2023 | 32 | $1.13M |
| Q1 2023 | 40 | $3.02M |
| Q4 2022 | 39 | $3.74M |
| Q3 2022 | 43 | $6.87M |
| Q2 2022 | 51 | $7.64M |
| Q1 2022 | 43 | $21.5M |
| Q4 2021 | 44 | $18.0M |
| Q3 2021 | 34 | $10.2M |
| Q2 2021 | 37 | $13.3M |
| Q1 2021 | 41 | $9.60M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Lunai Bioworks Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 497,011 | $438.4K | 0.00% | −20,614−4.0% | Reduced |
| Millennium Management LLC | 166,744 | $147.0K | 0.00% | −35,885−17.7% | Reduced |
| Geode Capital Management, LLC | 131,015 | $115.6K | 0.00% | +4,472+3.5% | Added |
| BlackRock, Inc. | 127,314 | $112.3K | 0.00% | +320.0% | Added |
| Northern Trust Corp | 37,402 | $33.0K | 0.00% | +16,000+74.8% | Added |
| State Street Corp | 35,728 | $31.5K | 0.00% | 00.0% | Unchanged |
| Nine Masts Capital Ltd | 24,220 | $21.4K | 0.00% | +24,220 | New |
| Citadel Advisors LLC | 20,632 | $18.2K | 0.00% | +20,632 | New |
| UBS Group AG | 17,940 | $15.8K | 0.00% | −19,430−52.0% | Reduced |
| Jane Street Group, LLC | 11,900 | $10.5K | 0.00% | +11,900 | New |
| Simplex Trading, LLC | 10,917 | $9.63K | 0.00% | +10,917 | New |
| Goldman Sachs Group Inc | 10,869 | $9.58K | 0.00% | −3,558−24.7% | Reduced |
| Commonwealth Equity Services, LLC | 10,157 | $8.96K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,869 | $5.17K | 0.00% | +246+4.4% | Added |
| Morgan Stanley | 2,614 | $2.31K | 0.00% | −9−0.3% | Reduced |
| Group One Trading, L.P. | 1,860 | $1.64K | 0.00% | +100+5.7% | Added |
| Fortitude Family Office, LLC | 473 | $417 | 0.00% | +473 | New |
| Bank of America Corp | 257 | $226 | 0.00% | −2,503−90.7% | Reduced |
| BNP Paribas Arbitrage, SA | 161 | $142 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 82 | $72 | 0.00% | +82 | New |
| Optiver Holding B.V. | 9 | $8 | 0.00% | +9 | New |
| Deutsche Bank AG | 1 | $1 | 0.00% | +1 | New |
| SBI Securities Co., Ltd. | 1 | $1 | 0.00% | +1 | New |
| Royal Bank of Canada | 44 | $0 | 0.00% | −102−69.9% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −37,761−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −16,417−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |